XLR8 PLUS (XLR8+)

K143726 · Genadyne Biotechnologies, Inc. · OMP · Jun 19, 2015 · General, Plastic Surgery

Device Facts

• Record ID: K143726
• Device Name: XLR8 PLUS (XLR8+)
• Applicant: Genadyne Biotechnologies, Inc.
• Product Code: OMP · General, Plastic Surgery
• Decision Date: Jun 19, 2015
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 878.4780
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The XLR8 Plus (XLR8+) Wound Vacuum System is indicated for use in patients who would benefit from negative pressure wound therapy particularly as the device may promote wound healing by the removal of excess exudates, infectious material and tissue debris.

Device Story

Portable, rechargeable battery-powered suction pump; generates negative pressure to remove wound exudate. Used in clinical or home settings; operated by healthcare providers or patients. Inputs: wound exudate via disposable canisters (200-1100 ml) with hydrophobic shut-off filters. Outputs: controlled negative pressure (up to 230 mmHg). Enhances wound healing by clearing debris and infectious material. Device provides therapy via connected dressing kits (foam, gauze, port pads, transparent film).

Clinical Evidence

No clinical data provided; substantial equivalence is based on bench testing and comparison of technological characteristics.

Technological Characteristics

Powered suction pump; rechargeable Li-Ion battery; 30W power. Max vacuum 230 mmHg; suction capacity >5 L/min. Dimensions 5.9" x 4" x 3.4"; weight 1.65 lbs. Disposable canisters (200-1100 ml) with hydrophobic shut-off filters. Compliance: IEC 60601-1, IEC 60601-1-2. Non-sterile device.

Indications for Use

Indicated for patients requiring negative pressure wound therapy to promote healing via removal of exudate, infectious material, and tissue debris. Contraindicated for necrotic tissue, untreated osteomyelitis, malignancy (unless for quality of life), untreated malnutrition, and exposed arteries, veins, or organs.

Regulatory Classification

Identification

A powered suction pump is a portable, AC-powered or compressed air-powered device intended to be used to remove infectious materials from wounds or fluids from a patient's airway or respiratory support system. The device may be used during surgery in the operating room or at the patient's bedside. The device may include a microbial filter.

Predicate Devices

• A4-XLR8 Wound Vacuum System (K090638)

Reference Devices

• A4-XLR8 Foam Dressing (K092992)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an emblem featuring a stylized representation of three human profiles facing to the right, resembling a bird-like shape.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

June 19, 2015

Genadyne Biotechnologies Incorporated Chien-Ming Goh Vice President, Regulatory Affairs 16 Midland Avenue Hicksville, New York 11801

Re: K143726

Trade/Device Name: Genadyne XLR8 Plus (XLR8+) Negative Pressure Wound Therapy Regulation Number: 21 CFR 878.4780 Regulation Name: Powered suction pump Regulatory Class: Class II Product Code: OMP Dated: May 14, 2015 Received: May 18, 2015

Dear Chien-Ming Goh:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical

{1}------------------------------------------------

device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

# David Krause -S

- Binita S. Ashar, M.D., M.B.A., F.A.C.S. for Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure

{2}------------------------------------------------

# Indications for Use

510(k) Number (if known) K143726

Device Name

Genadyne XLR8 Plus (XLR8+) Negative Pressure Wound Therapy

Indications for Use (Describe)

The XLR8 Plus (XLR8+) Wound Vacuum System is indicated for use in patients who would benefit from negative pressure wound therapy particularly as the device may promote wound healing by the removal of excess exudates, infectious material and tissue debris.

| Type of Use (Select one or both, as applicable) | |
|----------------------------------------------------------------------------------|----------------------------------------------------------------------|
| <input checked="" type="checkbox"/> Prescription Use (Part 21 CFR 801 Subpart D) | <input type="checkbox"/> Over-The-Counter Use (21 CFR 801 Subpart C) |

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

## Traditional 510k Summary

Negative Pressure Wound Therapy

Genadyne Biotechnologies, Inc. 16 Midland Ave, Hicksville, NY 11801

E-mail: [e-mail] (t) 516.217.0101 (f) 516.977.8974

Contact Person: Mr. Chien-Ming GOH (Andrew)

Date Prepared: December 23, 2014

Name of Device

XLR8 Plus (XLR8+) Neqative Pressure Wound Therapy

### Common or Usual Name

Powered Suction Pump

### Classification Name

OMP, Negative Pressure Wound Therapy Powered Suction Pump

21 C.F.R. § 878.4780

#### Predicate Device

A4-XLR8 Wound Vacuum System, K090638

#### Device Description

The XLR8 Plus (XLR8+) Wound Vacuum System is a portable, rechargeable battery powered wound suction pump with the intention to generate negative pressure to remove exudate from the wound.

#### Intended Use / Indications for Use

The XLR8 Plus (XLR8 +) Wound Vacuum System is indicated for use in patients who would benefit from negative pressure wound therapy particularly as the device may promote wound healing by the removal of excess exudates, infectious material and tissue debris.

{4}------------------------------------------------

# Technological Characteristics

| | Comparative Information | |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | Predicate Device | New Device |
| Company | Genadyne Biotechnologies | Genadyne Biotechnologies |
| Device Name | A4-XLR8 Wound Vacuum<br>System | XLR8 Plus (XLR8+) Wound Vacuum<br>System |
| 510 (K) Number | K090638 | |
| | | |
| Technical Data | | |
| Suction Capacity | 3.5 liters per minute | > 5 liters per minute |
| Max Vacuum | 230 mmHg | 230 mmHg |
| Power Requirements | 30W | 30W |
| Battery Type | Rechargeable Li-Ion | Rechargeable Li-Ion |
| Dimensions / Weight | 5.9" x 4" x 2.4" / 1.5 lbs | 5.9" x 4" x 3.4" / 1.65 lbs |
| | | |
| Accessories | | |
| Canisters | 200, 400, 600, 800 ml<br>disposable canister with a<br>build-in hydrophobic shut off<br>filter for overflow protection | 200, 400, 600, 800 & 1100 ml<br>disposable canister with a build-in<br>hydrophobic shut off filter for overflow<br>protection |
| | | |
| Reusable | No | No |
| | | Non Sterile |
| Sterile | Non Sterile | |
| Accessory Kit | | |
| | A4-XLR8 Foam Dressing<br>(K092992) | A4-XLR8 Foam Dressing (K092992)<br>XLR8 Bridge Dressing<br>XLR8 Port Pad<br>XLR8 Transparent Film<br>Gauze Dressing with Silicone Drain<br>Gauze Dressing with XLR8 Port Pad |
| Indications for Use | | |
| | Genadyne A4-XLR8 Wound<br>Vacuum System is indicated<br>for use in patients who would<br>benefit from negative pressure<br>wound therapy particularly as<br>the device may promote wound | Genadyne XLR8 Plus Wound<br>Vacuum System is indicated for use<br>in patients who would benefit from<br>negative pressure wound therapy<br>particularly as the device may<br>promote wound healing by the |
| | healing by the removal of<br>excess exudates, infectious<br>material and tissue debris. | removal of excess exudates.<br>infectious material and tissue debris. |
| | | |
| Contraindications | | |
| | The Genadyne A4-XLR8 is<br>contraindicated in the presence<br>of : | The Genadyne XLR8 Plus is<br>contraindicated in the presence of: |
| - | Necrotic tissue | Necrotic tissue |
| - | Untreated osteomyelitis | Untreated osteomyelitis |
| - | Malignancy (with exception to<br>enhance quality of life) | Malignancy (with exception to<br>enhance quality of life) |
| - | Untreated malnutrition | Untreated malnutrition |
| - | Exposed arteries, veins, or<br>organs | Exposed arteries, veins, or organs |
| Precautions | | |
| | Precautions should be taken<br>for patients who are or may be: | Precautions should be taken for<br>patients who are or may be: |
| - | Receiving anticoaqulant<br>therapy | Receiving anticoaqulant therapy |
| - | Suffering from difficult<br>hemostasis | Suffering from difficult hemostasis |
| - | Untreated for malnutrition | Untreated for malnutrition |
| - | Non-complaint or combative | Non-complaint or combative |
| Compliance | | |
| | IEC 60601-1, 3rd Edition | IEC 60601-1 |
| | | IEC 60601-1-2 |
| | | |
| Storage / Transport | | |
| | -18°C to +43°C (0°F to 110°F) | -18°C to +43°C (0°F to 110°F) |
| | Relative Humidity 10% to 95 % | Relative Humidity 10% to 95 % |
| | 700 - 1060 mbar Atmospheric<br>pressure | 700 - 1060 mbar Atmospheric<br>pressure |
| | | |
| Operation | 18°C to 34°C (65°F to 94°F) | 18°C to 34°C (65°F to 94°F) |
| | Relative Humidity 10% to 95 % | Relative Humidity 10% to 95 % |
| | 700 - 1060 mbar Atmospheric<br>pressure | 700 - 1060 mbar Atmospheric<br>pressure |

Table of Comparison to Predicate Devices:

{5}------------------------------------------------

Conclusion & 15. Determination of Substantial Equivalence Based on the information presented above, it is concluded that the XLR8 Plus (XLR8+) is substantially equivalent to the predicate device.